Steris (STE) Net Margin Growth (3y) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -315.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,018.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 399.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | -129.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -779.00 |
| Dec 31, 2024 | -1,184.00 |
| Sep 30, 2024 | -583.00 |
| Jun 30, 2024 | 270.00 |
| Mar 31, 2024 | -2,522.00 |
| Dec 31, 2023 | -1,476.00 |
| Sep 30, 2023 | -1,438.00 |
| Jun 30, 2023 | -1,396.00 |
| Mar 31, 2023 | -1,305.00 |
| Dec 31, 2022 | -1,799.00 |
| Sep 30, 2022 | -5,317.00 |
| Jun 30, 2022 | -1,292.00 |
| Mar 31, 2022 | -536.00 |
| Dec 31, 2021 | 488.00 |
| Sep 30, 2021 | -560.00 |
| Jun 30, 2021 | -1,326.00 |
| Mar 31, 2021 | -2,490.00 |